Provided by Tiger Trade Technology Pte. Ltd.

Edesa Biotech

5.82
-0.0400-0.68%
Post-market: 5.860.0400+0.69%19:59 EDT
Volume:224.67K
Turnover:1.31M
Market Cap:48.50M
PE:-5.09
High:6.12
Open:5.74
Low:5.60
Close:5.86
52wk High:9.37
52wk Low:0.7200
Shares:8.33M
Float Shares:4.28M
Volume Ratio:0.21
T/O Rate:5.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1438
EPS(LYR):-1.2658
ROE:-96.38%
ROA:-55.33%
PB:10.42
PE(LYR):-4.60

Loading ...

Skin drug developer Edesa Biotech's FY net loss widens to $7.2 mln

Reuters
·
Dec 13, 2025

Edesa Biotech Q4 EPS $(0.32) Misses $(0.27) Estimate

Benzinga
·
Dec 13, 2025

Edesa Biotech Inc. reports FY research and development expenses of USD 3.7 million, up 27%

Reuters
·
Dec 13, 2025

Edesa Biotech FY Operating Expenses USD 7.9 Million

THOMSON REUTERS
·
Dec 13, 2025

Press Release: Edesa Biotech Reports Fiscal Year 2025 Results

Dow Jones
·
Dec 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 11, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 08, 2025

Edesa Biotech (EDSA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Nov 04, 2025

Edesa Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 04, 2025

Edesa Biotech to Participate in Key Industry Conferences

TIPRANKS
·
Nov 01, 2025

Edesa Biotech Announces Upcoming Conference Schedule

GlobeNewswire
·
Nov 01, 2025

BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study

Reuters
·
Oct 28, 2025

Edesa Biotech Reports Positive Phase 3 Results for ARDS Drug Paridiprubart

Reuters
·
Oct 28, 2025

Edesa Biotech Inc - Paridiprubart Shows 25% Reduction in Risk of Death

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech Inc - Eb05 Well-Tolerated in Safety Population of Over 275 Subjects

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech Inc: Study Met Primary and Secondary Endpoints

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment

TIPRANKS
·
Oct 28, 2025

Edesa Biotech Amends $23 Million Funding Agreement with Government of Canada, Extends Repayment Timeline and Expands ARDS Drug Focus

Reuters
·
Oct 01, 2025